RVLP - RVL Pharmaceuticals plc GAAP EPS of -$0.18 misses by $0.01 revenue of $9.81M misses by $2.72M
2023-03-20 07:07:48 ET
- RVL Pharmaceuticals plc press release ( NASDAQ: RVLP ): Q4 GAAP EPS of -$0.18 misses by $0.01 .
- Revenue of $9.81M (+243.0% Y/Y) misses by $2.72M .
- At December 31, 2022, cash and cash equivalents were $44.5 million and long-term debt had an aggregate principal amount of $75.0 million.
For further details see:
RVL Pharmaceuticals plc GAAP EPS of -$0.18 misses by $0.01, revenue of $9.81M misses by $2.72M